Expert Interviews

Physiatrist Abby Cheng, MD, an author of the AAPM&R Long COVID Mental Health Consensus Guidance Statement, discusses why the symptoms can be confusing.

Reducing stigma associated with chronic liver disease and expediting diagnosis and referral will take some time but progress is being made, Luxon says.

Transplant hepatologist Dr Bruce Luxon says primary care is essential to making progress against chronic liver disease but doesn't have the resources it needs.

Dr Nancy Reau, presents the case of a 59-Year-Old male, who was admitted to the ICU after his family was unable to wake him and comments on the role of TIPS and SPSS shunting in the management of hepatic encephalopathy.

Nancy Reau, MD presents the case of a 64-Year-Old female, who presented to the clinic after a recent car accident and discusses how she approached her treatment plan.

Arun Jesudian, MD, details key findings from a study he recently presented at The Liver Meeting 2023.

Physiatrist Saloni Sharma, MD, stresses the essential role of coordinated, multidisciplinary care for a person with neuropathic pain—and any person with limited function.

An expert in the management of hypothyroidism discusses the circumstances that might warrant a referral to an endocrinologist. She further focuses on how to set the appropriate visit frequency and emphasizes how to empower patients to actively participate in their care.

Dr. Lizzy McAninch, comments on the intricate details of LT4 medication administration, including the need for dose titration to normalize hormone levels and achieve treatment goals. She highlights the need for flexibility in accommodating patients' individual preferences and lifestyles regarding the timing and manner of LT4 medication ingestion, all while stressing the critical importance of consistent laboratory monitoring

Lizzy McAninch, MD discusses primary therapy goals for patients with hypothyroidism, highlighting the importance of normalizing serum TSH, alleviating symptoms, and avoiding overmedication. She emphasizes that symptoms can persistent even when target TSH levels have been met; necessitating discussions between patients and healthcare providers to set treatment expectations, with a focus on symptom relief and personalized treatment optimization due to the lifelong nature of this condition.